Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
125 studies found for:    Open Studies | "Skin Diseases, Infectious"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Human Immunity Against Staphylococcus Aureus Skin Infection
Condition: Staphylococcus Aureus Skin Infection
Intervention: Other: Killed Bacteria
2 Recruiting Skin and Soft Tissue Infection (SSTI) Study
Conditions: Skin Diseases, Infectious;   Soft Tissue Infections
Interventions: Drug: Provodine;   Procedure: Incision and Drainage
3 Recruiting Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)
Conditions: Skin Diseases, Infectious;   Skin Diseases, Bacterial
Interventions: Drug: Tedizolid Phophate 200 mg, IV and/or oral for 6 days;   Drug: Antibiotic comparator
4 Recruiting Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute Skin Infections
Conditions: Skin Diseases, Bacterial;   Abscess
Interventions: Biological: Linezolid;   Biological: Clindamycin
5 Not yet recruiting Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA
Conditions: Methicillin-Resistant Staphylococcus Aureus;   Bacterial Infections;   Staphylococcal Skin Infections
Interventions: Drug: Dalbavancin single dose;   Drug: Dalbavancin two dose;   Drug: Comparator
6 Recruiting Comparing the Intravenous Treatment of Skin Infections in Children, Home Versus Hospital
Condition: Cellulitis
Interventions: Other: Home;   Other: Ward;   Drug: ceftriaxone;   Drug: flucloxacillin
7 Recruiting Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence
Conditions: Methicillin-Resistant Staphylococcus Aureus;   Recurrence;   Staphylococcal Skin Infections;   Antibiotic Resistance
Interventions: Drug: 2% mupirocin ointment;   Other: Chlorhexidine wash;   Behavioral: Hygiene protocol
8 Not yet recruiting Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis
Condition: Tinea
Interventions: Drug: Ketoconazole + betamethasone dipropionate;   Drug: Clotrimazole + Dexamethasone acetate
9 Not yet recruiting Safety of Either a Single or Two IV Doses of Orbactiv in Subjects With ABSSSI
Condition: Skin Diseases, Bacterial
Interventions: Drug: oritavancin;   Drug: placebo (D5W)
10 Recruiting Use of a Single Dose of Oral Prednisone in the Treatment of Cellulitis
Condition: Cellulitis
Interventions: Drug: Prednisone;   Drug: Placebo
11 Recruiting Use of Corticosteroids in Children With Cellulitis
Condition: Cellulitis
Interventions: Drug: Dexamethasone;   Drug: Normal Saline
12 Recruiting Safety and Efficacy of Product 33525 in Pediatric Subjects With Tinea Corporis
Condition: Tinea Corporis
Interventions: Drug: Luliconazole Cream 1%;   Drug: Vehicle Cream
13 Not yet recruiting A Randomized Study Evaluating the Safety and Efficacy of Luliconazole Cream in Pediatric Subjects With Tinea Corporis
Condition: Tinea
Interventions: Drug: Luliconazole Cream 1%;   Drug: Vehicle Cream
14 Recruiting Duration of ANtibiotic Therapy for CEllulitis
Conditions: Cellulitis;   Erysipelas
Interventions: Drug: Flucloxacillin;   Drug: Placebo (for flucloxacillin)
15 Not yet recruiting Accuracy of a Rapid Diagnostic Test for Cutaneous Leishmaniasis in Morocco
Conditions: Cutaneous Leishmaniasis;   Skin Diseases, Parasitic;   Neglected Diseases
Intervention:
16 Recruiting CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis
Condition: Candidiasis, Chronic Mucocutaneous
Intervention: Drug: Amphotericin B
17 Recruiting Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101)
Condition: Aspergillosis
Interventions: Drug: Posaconazole;   Drug: Voriconazole
18 Recruiting A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)
Condition: Fungal Infections
Interventions: Drug: Posaconazole;   Drug: Voriconazole
19 Recruiting Study to Evaluate Safety, Tolerability, and Pharmacokinetics of UB-621 in Healthy Volunteers
Condition: Herpes Simplex Virus Infection
Intervention: Drug: UB-621
20 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Pain;   Reflux;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure);   Infantile Hemangioma;   Withdrawal;   Inflammation;   Bacterial Septicemia;   Cytomegalovirus Retinitis;   Herpes Simplex Virus;   Adenovirus;   Brain Swelling;   Airway Swelling;   Adrenal Insufficiency;   Anxiety;   Nausea;   Vomiting;   Convulsions;   Muscle Spasms;   Seizures;   Epilepsy;   Bartonellosis;   Brucellosis;   Cholera;   Plague;   Psittacosis;   Q Fever;   Relapsing Fever;   Rocky Mountain Spotted Fever;   Trachoma;   Tularemia;   Typhus Fever;   Bronchospasm;   Cardiac Arrest;   Hypersensitivity Reaction;   Cyanide Poisoning;   Acute Bacterial Sinusitis;   Bacterial Meningitis;   Sepsis;   Gastroparesis;   Opioid Addiction;   Migraines;   Headaches
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.